Risperidone and Gastrointestinal pain - a phase IV clinical study of FDA data
Gastrointestinal pain is found among people who take Risperidone, especially for people who are male, 30-39 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Risperidone and have Gastrointestinal pain. It is created by eHealthMe based on reports of 56,557 people who have side effects when taking Risperidone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
56,557 people reported to have side effects when taking Risperidone.
Among them, 19 people (0.03%) have Gastrointestinal pain.
What is Risperidone?
Risperidone has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 57,842 Risperidone users for its effectiveness, alternative drugs and more.
What is Gastrointestinal pain?
Gastrointestinal pain is found to be associated with 1,101 drugs and 700 conditions by eHealthMe.
Number of Risperidone and Gastrointestinal pain reports submitted per year:
Time on Risperidone when people have Gastrointestinal pain *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 100 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Gastrointestinal pain when taking Risperidone *:
- female: 31.58 %
- male: 68.42 %
Age of people who have Gastrointestinal pain when taking Risperidone *:
- 0-1: 0.0 %
- 2-9: 30.77 %
- 10-19: 0.0 %
- 20-29: 7.69 %
- 30-39: 30.77 %
- 40-49: 0.0 %
- 50-59: 23.08 %
- 60+: 7.69 %
Common drugs people take besides Risperidone *:
- Pantoprazole: 9 people, 47.37%
- Sertraline: 7 people, 36.84%
- Lamotrigine: 3 people, 15.79%
- Lamictal: 1 person, 5.26%
- Biotin: 1 person, 5.26%
- Buspar: 1 person, 5.26%
- Cytotec: 1 person, 5.26%
- Diazepam: 1 person, 5.26%
- Felodipine: 1 person, 5.26%
- Fish Oil: 1 person, 5.26%
Common side effects people have besides Gastrointestinal pain *:
- Diarrhea: 11 people, 57.89%
- Headache (pain in head): 10 people, 52.63%
- Insomnia (sleeplessness): 10 people, 52.63%
- Persecutory Delusion: 9 people, 47.37%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 9 people, 47.37%
- Fear Of Disease: 9 people, 47.37%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 9 people, 47.37%
- Delusion (a false belief or opinion): 9 people, 47.37%
- Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 9 people, 47.37%
- Borderline Personality Disorder: 9 people, 47.37%
Common conditions people have *:
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 15.79%
- Agitated Depression: 3 people, 15.79%
- Yellow Fever (acute viral circulation system bleeding disease): 1 person, 5.26%
- Psychotic Disorder: 1 person, 5.26%
- Procedural Pain: 1 person, 5.26%
- Oesophageal Spasm (contraction of oesophagus): 1 person, 5.26%
- Insomnia (sleeplessness): 1 person, 5.26%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 5.26%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 5.26%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Risperidone and have Gastrointestinal pain?Check whether Gastrointestinal pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Janardhana P, Nagaraj AK, Basavanna PL, "Risperidone-induced skin rash", Indian journal of psychiatry, 2016 Jan .
- Dsouza MC, "Could risperidone have caused the cataract?: A case report and review of literature", Journal of Research in Psychiatry and Behavioral Science, 2015 Jan .
- Dsouza MC, "COULD RISPERIDONE HAVE CAUSED THE CATARACT", JRPBS, 2015 Jan .
- Ray RK, Bashir MA, Rao S, "Co-Administration of Risperidone and Sodium Valproate Causing Bilateral Chronic Exertional Lower Leg Compartment Syndrome", Open Journal of Orthopedics, 2014 Apr .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Alternative drugs to, pros and cons of Risperidone:
- Risperidone (57,842 reports)
Gastrointestinal pain treatments and more:
- Gastrointestinal pain (9,773 reports)
COVID vaccines that are related to Gastrointestinal pain:
- Gastrointestinal pain in Moderna COVID Vaccine
- Gastrointestinal pain in Pfizer BioNTech Covid Vaccine
- Gastrointestinal pain in Johnson and Johnson Covid Vaccine
How severe was Gastrointestinal pain and when was it recovered:
Expand to all the drugs that have ingredients of risperidone:
Common drugs associated with Gastrointestinal pain:
All the drugs that are associated with Gastrointestinal pain:
- Gastrointestinal pain (1,101 drugs)
Common conditions associated with Gastrointestinal pain:
All the conditions that are associated with Gastrointestinal pain:
- Gastrointestinal pain (700 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on risperidone (the active ingredients of Risperidone) and Risperidone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.